Xxxxxx, Duties and Composition Sample Clauses

Xxxxxx, Duties and Composition. The powers and duties of the regional school district (hereinafter sometimes referred to as “the District”) shall be vested in and exercised by a regional district school committee (hereinafter sometimes referred to as “the Committee”). The Committee shall consist of ten (10) members of whom five (5) members shall be elected from Rehoboth and five (5) members shall be elected from Dighton. Elected members shall be those elected at annual town elections. Members shall serve until their respective successors are elected and qualified. To meet the requirement of proportional representation (one-person, one-vote) respective to the population of each member town, the votes of each of the ten (10) members will be weighted according to the relative populations of the two member towns. Based on the 2010 Federal Census beginning with the final approvals of this amended Agreement, the five (5) members from Rehoboth will each receive 1.2 votes and the five (5) members from Dighton will each receive a 0.8 vote. Every tenth year, following publication of the decennial federal census, and every five
Sample 1
AutoNDA by SimpleDocs
Xxxxxx, Duties and Composition. The powers and duties of the regional school district (hereinafter sometimes referred to as “the District”) shall be vested in and exercised by a regional district school committee (hereinafter sometimes referred to as “the Committee”). Except as provided herein and in subsection I-B, The Committee shall consist of ten (10) members of whom five (5) members shall be elected from Rehoboth and five (5) members shall be elected from Dighton. Elected members shall be those elected at annual town elections. Members shall serve until their respective successors are elected and qualified. To meet the requirement of proportional representation (one-person, one-vote) respective to the population of each member town, the votes of each of the ten (10) members will be weighted according to the relative populations of the two member towns. Based on the 2010 Federal Census beginning with the final approvals of this amended Agreement, the five (5) members from Rehoboth will each receive 1.2 votes and the five (5) members from Dighton will each receive a 0.8 vote. Every tenth year, following publication of the decennial federal census, and every five (5) years in between, based on official state census figures, the Committee shall review the weighted votes assigned to members from each member town on the Committee. If the then relative population of the two member towns deviates from the relative numbers of the weighed Committee votes, the weighted votes will be changed to reflect the relative member town populations as near as practical, but within a ten percent (10%) range. each elected member from the Town of Rehoboth will have one (1) vote for a total of five (5) votes while each elected member from the Town of Dighton will have eight-tenths (.8) vote for a total of four (4) votes. In 1991 and every tenth year thereafter, following publication of the decennial federal census, the Committee shall review the weighted votes assigned to members from each town on the Committee, and if it considers changes are required in order to ensure as far as practicable that the number of votes from each town remains in approximate proportion to the respective population of the member town, shall prepare an amendment to this agreement for that purpose.
Sample 1
Xxxxxx, Duties and Composition. (1) The powers and duties of the Regional School District (hereinafter referred to as the District) shall be vested in and exercised by a Regional District School Committee, hereinafter referred to as the Committee. The Committee shall consist of ten (10) members of which five (5) members shall be elected from Rehoboth and five (5) members shall be elected from Dighton. Elected members shall be those elected at annual town elections. Members shall serve until their respective successors are elected and qualified and at least until June 30 of the year in which their term expires. To meet the requirement of proportional representation (one-man-one-vote) respective to the population of each member town, the votes of each of the ten (10) members will be weighted according to the relative populations of the two member towns. Every tenth year, following publication of the decennial federal census, and every five (5) years in between, based on official state census figures, the Committee shall review the weighted votes assigned to members from each member town on the Committee. If the then relative population of the two member towns deviates from the relative numbers of the weighted Committee votes, the weighted votes will be changed to reflect the relative member town populations as near as practical, but within a ten percent (10%) range.
Sample 1

Related to Xxxxxx, Duties and Composition

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK Firms and/or individuals that assisted in the development or drafting of the specifications, requirements, statements of work, or solicitation documents contained herein are excluded from competing for this solicitation. This shall not be applicable to firms and/or individuals providing responses to a publicly posted Request for Information (RFI) associated with a solicitation.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Board Composition Each Stockholder agrees to vote, or cause to be voted, all Shares owned by such Stockholder, or over which such Stockholder has voting control, from time to time and at all times, in whatever manner as shall be necessary to ensure that at each annual or special meeting of stockholders at which an election of directors is held or pursuant to any written consent of the stockholders, the following persons shall be elected to the Board:

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Composition of the Board At and following the Closing, each of the Partners and the Sponsor, severally and not jointly, agrees to take, for so long as such Party holds of record or beneficially owns any Registrable Securities, all Necessary Action to cause the Board to be comprised of eleven (11) directors nominated in accordance with this Article II, initially consisting of (i) seven (7) of whom have been nominated by the Partners, and thereafter designated pursuant to Section 2.1(b) or Section 2.1(d) of this Investor Rights Agreement (each, a “Partner Director”), at least four (4) of whom shall satisfy all applicable independence requirements (including at least two (2) of whom shall be sufficiently independent to serve on the audit and compensation committees of the Board), (ii) three (3) of whom have been nominated by the Sponsor, and thereafter designated pursuant to Section 2.1(c) or Section 2.1(d) of this Investor Rights Agreement (each, a “Sponsor Director”), at least one (1) of whom shall satisfy all applicable independence requirements (including being sufficiently independent to serve on the audit committee of the Board as a chair and the compensation committee as a member), and (iii) one (1) of whom has been jointly nominated by the mutual agreement of Sponsor and the Partners (the “Joint Director”), which Joint Director shall satisfy all applicable independence requirements. At and following the Closing, each of the Sponsor and the Partners, severally and not jointly, agrees to take, for so long as such Party holds of record or beneficially owns any Registrable Securities, all Necessary Action to cause the foregoing directors to be divided into three (3) classes of directors, with each class serving for staggered three (3) year terms. The initial term of the Class I directors shall expire immediately following PubCo’s 2022 annual meeting of stockholders at which directors are elected. The initial term of the Class II directors shall expire immediately following PubCo’s 2023 annual meeting of stockholders at which directors are elected. The initial term of the Class III directors shall expire immediately following PubCo’s 2024 annual meeting at which directors are elected.

Time is Money Join Law Insider Premium to draft better contracts faster.